Go to the list of all blogs
Alicia's Avatar
published in Blogs
Apr 03, 2026
Unilever PLC (UL): Analyzing the -20% Drop and What Lies Ahead

Unilever PLC (UL): Analyzing the -20% Drop and What Lies Ahead

Key Takeaways

  • Unilever PLC (UL) stock has declined approximately -20% over the past 30 days amid heightened volatility following the announcement of a major deal to combine its Foods business with McCormick, contributing to investor concerns over execution and valuation.
  • Over the past quarter, the stock is down around -14%, reflecting broader market pressures, currency headwinds, and strategic portfolio shifts including the Ice Cream demerger.
  • Key drivers include the March 31, 2026, Foods-McCormick transaction announcement, which led to a sharp 5% drop on March 31 and continued selling; analyst downgrades; and slowing consumer goods sector sentiment.
  • Despite solid 2025 full-year results with 3.5% underlying sales growth and margin expansion, stock price movement has been trend-driven downward with increased volume on negative news.
  • Macro factors like adverse currencies and subdued emerging market demand have compounded company-specific events.

Unilever PLC (UL): A Look at the Company and Its Market Position

Unilever PLC (UL) stands as a multinational consumer goods giant, producing and selling a broad portfolio that spans personal care products like Dove and Vaseline, beauty and wellbeing brands, home care items such as Domestos, and foods including Hellmann’s and Knorr. The company's business model centers on its power brands, which drive 78% of turnover, with a focus on premiumization, digital commerce, and innovation in high-growth areas like Beauty & Wellbeing and Personal Care. In the competitive consumer staples sector, Unilever maintains a strong global footprint, particularly in emerging markets like India and the US. Its fundamentals remain robust, evidenced by a 20.0% underlying operating margin in 2025 and €5.9 billion in free cash flow. From what I see, these strengths underpin the company's resilience even as the stock faces recent declines, with portfolio reshaping aimed at higher-growth segments amid currency volatility and market slowdowns.

Unilever (UL) Stock Performance: The Past 30 Days and Quarter in Review

In the last 30 days, UL stock has dropped sharply by about -20%, moving from a closing price of approximately $69.15 around March 3, 2026, to $55.45 as of April 2, 2026. The decline has been volatile and decidedly downward-trending, accelerating after March 31 with a -5% drop to $56.97 and further slides to a 52-week low near $54.95.

Over the past quarter, the stock is down roughly -14%, from around $64.56 in early January 2026 to current levels. It started range-bound but shifted lower on news events, accompanied by elevated trading volume on key days that surpassed 18 million shares.

Breaking Down the Drivers Behind UL's 30-Day Decline

The main trigger for UL's 30-day drop was the March 31, 2026, announcement of a $44.8 billion deal to combine Unilever's Foods business (excluding India) with MKC, forming a $20 billion flavor entity. Unilever shareholders would own 65% of the combined company plus $15.7 billion in cash, yet the market reacted poorly to the complex Reverse Morris Trust structure, the long timeline to close by mid-2027, antitrust risks, and potential dilution. This sparked a 5-7% single-day plunge, erasing billions in market value. Ongoing pressure stemmed from analyst downgrades—like those from DZ Bank and Kepler moving from Buy to Hold—and reports of a global hiring freeze amid challenges such as the U.S.-Iran war. Weakening sentiment in consumer staples, driven by slowing demand, added to the downtrend. I also checked this using Tickeron’s AI Screener to gauge how the stock stacks up against industry peers.

UL's Quarterly Performance: Building Pressures Over Time

The -14% quarterly decline in UL built from earlier headwinds exposed in the February 12, 2026, Q4/full-year 2025 earnings, which delivered 3.5% underlying sales growth but missed on revenue ($12.59B vs. expectations) and EPS ($0.75 vs. $1.75). Currency headwinds at -5.9% and the Ice Cream demerger weighed on free cash flow. Persistent themes included portfolio transformation via 10 M&A deals, with strength in Beauty & Wellbeing (4.3% growth), but concerns over emerging market slowdowns—like in Latin America—and institutional selling persisted. Macro factors such as inflation, higher rates, and regulatory scrutiny on deals intensified the pressure, culminating in the McCormick news. Unilever's defensive qualities provided some buffer, though overall sentiment turned negative.

Discovering Trending AI Robots for Smarter Trading

In my own research process, I often turn to Tickeron’s Trending AI Robots page, which highlights the top performers from its library of hundreds of algorithms trading thousands of tickers across markets. This section focuses on the most relevant bots based on recent results, employing strategies like momentum, mean reversion, or scalping, and key metrics such as win rate, Sharpe ratio, and average returns across timeframes from intraday to long-term. Powered by advanced machine learning, these bots analyze price movements and trends without emotional interference, helping me uncover data-driven opportunities. One thing that stands out is how they can align with different trading styles to potentially improve portfolio outcomes—worth exploring if you're looking for an edge.

What to Watch in UL's Outlook: Key Drivers Ahead

Looking ahead, I'm watching progress on the McCormick Foods deal closely, including regulatory approvals and shareholder votes, as any delays or antitrust hurdles could shift sentiment. Upcoming quarterly earnings will shed light on 2026 guidance for 4-6% underlying sales growth (likely at the low end) and modest margin expansion. Trends like premiumization in Beauty & Wellbeing and e-commerce growth remain central. Broader factors—currency swings, inflation, interest rates, and geopolitical tensions impacting demand—deserve attention. Strategic moves such as the €1.5 billion share buyback, €800 million productivity savings target, and M&A in high-growth areas could support the stock, balanced against risks from hiring freezes or market slowdowns. This is important because these elements will shape near-term price action.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: UL

Contributor

Alicia's AvatarAlicia|Beginner

UL in +1.52% Uptrend, rising for three consecutive days on August 21, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where UL advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 20, 2026. You may want to consider a long position or call options on UL as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 190 cases where UL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for UL moved out of overbought territory on July 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for UL turned negative on August 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

UL broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.616) is normal, around the industry mean (23.642). P/E Ratio (21.215) is within average values for comparable stocks, (56.718). UL's Projected Growth (PEG Ratio) (11.611) is very high in comparison to the industry average of (2.919). Dividend Yield (0.035) settles around the average of (0.034) among similar stocks. P/S Ratio (2.388) is also within normal values, averaging (2.707).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 22.32B. The market cap for tickers in the group ranges from 81.32K to 336.3B. PG holds the highest valuation in this group at 336.3B. The lowest valued company is QNTA at 81.32K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was -0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -5%. EL experienced the highest price growth at 18%, while YSG experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 21%. For the same stocks of the Industry, the average monthly volume growth was 20% and the average quarterly volume growth was -41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 51
Price Growth Rating: 56
SMR Rating: 70
Profit Risk Rating: 91
Seasonality Score: -39 (-100 ... +100)
View a ticker or compare two or three
UL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of fast moving consumer goods

Industry HouseholdPersonalCare

Profile
Details
Industry
Household Or Personal Care
Address
100 Victoria Embankment
Phone
+44 2078225252
Employees
128000
Web
https://www.unilever.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
Unilever PLC (UL): Analyzing the -20% Drop and What Lies Ahead